Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listVinflunine Ditartrate

Vinflunine Ditartrate

Vinflunine Ditartrate Structural

What is Vinflunine Ditartrate?

Chemical properties

White Solid

The Uses of Vinflunine Ditartrate

Vinflunine Ditartrate can be used as Semisynthetic Vinca alkaloid with microtubule destabilizing and antiangiogenic activity; derivative of Vinorelbine.

The Uses of Vinflunine Ditartrate

Vinflunine is a semisynthetic Vinca alkaloid with microtubule destabilizing and antiangiogenic activity. Vinflunine is a derivative of Vinorelbine. Vinflunine is used as an antineoplastic.

Clinical Use

Vinflunine ditartrate is a second generation difluorinated analog of the naturally-occuring substance vinorelbine and it is approved for the treatment of non-small cell lung cancer, metastatic breast cancer and ovarian cancer. Vinflunine, a tubulin polymerization inhibitor, belongs to the vinca alkaloid class of anti-cancer agents. Introduction of the difluoro group of vinflunine dramatically improved antitumor activity of the parent vinorelbine structure. Vinflunine was discovered by Pierre Fabre Laboratories and in 2004 was licensed to Bristol-Myers Squibb for development and commercialization. In 2007, the rights to venflunine were returned to Pierre Fabre which completed its development.

Synthesis

Vinflunine can be prepared directly from vinorelbine (155) through the use of superacid chemistry. Reaction of 155 with antimony pentaflouride in hydrofluoric acid and Nbromosuccinimide followed by treatment with two equivalents of tartaric acid produced vinflunine ditartrate (XV) in 25% yield. An alternative synthesis of vinflunine was realized through reaction of vinblastine or 3?ˉ,4?ˉ-dihydrovinblastine (156) with antimony pentaflouride and hydrofluoric acid in chloroform to give the difluoro alkaloid 157 in 40% yield Ring contraction was effected by reaction with trifluoroacetic acid and N-bromosuccinimide followed by aqueous sodium bicarbonate and silver tetrafluoroborate to give vinflunine in 88% yield. Vinflunine ditartrate (XV) was prepared by treating a solution of vinflunine in toluene with two equivalents of tartaric acid.

Synthesis_194468-36-5

Properties of Vinflunine Ditartrate

Melting point: 244-246°C (dec)
storage temp.  -20°C Freezer
solubility  DMSO (Slightly), Methanol (Slightly)
form  Solid
color  White to Light Beige

Safety information for Vinflunine Ditartrate

Computed Descriptors for Vinflunine Ditartrate

Related products of tetrahydrofuran

You may like

  • Bendamustine deschloroethyl acid ethyl ester 2517968-40-8 NLT 95%
    Bendamustine deschloroethyl acid ethyl ester 2517968-40-8 NLT 95%
    2517968-40-8
    View Details
  • Acebutolol EP Impurity K NLT 95%
    Acebutolol EP Impurity K NLT 95%
    74143-33-2
    View Details
  • Clidinium Bromide Impurity NLT 95%
    Clidinium Bromide Impurity NLT 95%
    .6581-06-2
    View Details
  • 192110-67-2 NLT 95%
    192110-67-2 NLT 95%
    192110-67-2
    View Details
  • Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%
    Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%
    59872-62-1
    View Details
  • 90717-17-2 Ketamine Impurity-C NLT 95%
    90717-17-2 Ketamine Impurity-C NLT 95%
    90717-17-2
    View Details
  • .2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%
    .2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%
    .2005-04-1
    View Details
  • 145773-22-1 Lantanoprost rc B NLT 95%
    145773-22-1 Lantanoprost rc B NLT 95%
    145773-22-1
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.